Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reaffirms Positive Outlook on Nerdwallet with Increased Price Target

Elaine Mendonca by Elaine Mendonca
February 15, 2024
in Breaking News
0
FLO stock news
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On February 15, 2024, Justin Patterson, an analyst at Keybanc, reaffirmed his positive outlook on Nerdwallet (NASDAQ: NRDS) by maintaining an Overweight rating. Notably, he increased the price target for the company from $20 to $22. This adjustment follows a previous upward revision of the price target from $18 to $20. It is worth mentioning that there are conflicting reports regarding the price target, with one source suggesting a decrease from $25 to $22, while another source indicates an increase from $18 to $20. Given these discrepancies, it is advisable to consult the most recent and reliable source to obtain accurate information.

NRDS Stock Performance: Mixed Results and Potential Factors Influencing Price Decline and After-Hours Recovery

On February 15, 2024, NRDS stock exhibited mixed performance. The stock’s price experienced a slight decline of $0.24 or 1.45% during regular trading hours, closing at $16.32. However, in after-hours trading, NRDS shares managed to recover slightly, rising by $0.02. Trading in the middle of its 52-week range suggests stability, and being above its 200-day simple moving average indicates a positive long-term trend. The decline in price could be influenced by various factors, and the slight recovery in after-hours trading could indicate renewed investor confidence or the impact of late-breaking news. It is important for investors to conduct thorough research before making any investment decisions.

NRDS Stock Performance Holds Steady with Flat Total Revenue, Declining Net Income: February 15, 2024 Update

On February 15, 2024, NRDS stock showed a stable performance, with total revenue holding flat since the previous quarter. NRDS reported total revenue of $599.40 million over the past year, representing an increase of 11.23% compared to the previous year. In the fourth quarter, the company generated $133.70 million in total revenue, the same as the previous quarter. However, NRDS experienced a decline in net income, reporting a net income of -$11.80 million over the past year, reflecting a decrease of 15.69% compared to the previous year. In the fourth quarter, NRDS managed to improve its net income slightly, reporting -$2.30 million, an increase of 0.0% compared to the previous quarter. Unfortunately, information regarding NRDS earnings per share (EPS) is currently unavailable. The stability in total revenue and the slight improvement in net income during the fourth quarter indicate that NRDS is making efforts to maintain its financial position. However, the decline in net income over the past year might raise concerns among investors. Investors and analysts will likely be eager to obtain more information about NRDS’s earnings per share, as it provides a crucial insight into the company’s profitability on a per-share basis. In conclusion, NRDS stock showed a steady performance on February 15, 2024, with total revenue holding flat since the previous quarter. While net income experienced a decline over the past year, the company managed a slight improvement in the fourth quarter. The lack of data on earnings per share prevents a deeper analysis of NRDS’s profitability. Investors and analysts will be eagerly awaiting further updates to gain a clearer understanding of NRDS’s financial performance.

Tags: NRDS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Bull Market

KeyBanc Analyst Raises Price Target and Maintains Overweight Rating on Repligen NASDAQ RGEN

Aerospace and Defense Market Capitalization

Lockheed Martin Expands Production of Advanced Weapons Systems to Meet Global Demand

Biotechnology Stock Exchange

Unconventional Options Activity Surrounding Salesforce CRM Points to Positive Outlook

Recommended

SKYX Platforms Stock

Marriott Partnership Signals Major Breakthrough for SKYX Platforms

5 months ago
Microsoft Stock

Microsoft’s AI Ambition: A High-Stakes Bet on Future Growth

18 hours ago
Turtle Beach Stock

Turtle Beach Forges PlayStation Alliance with New Gaming Headset

5 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Trending

Rolls Royce Stock
Defense & Aerospace

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

by Dieter Jaworski
February 5, 2026
0

The coming weeks represent a critical juncture for Rolls-Royce. The company is poised to demonstrate whether it...

Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification
  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com